BOTHELL, Wash.--(BUSINESS WIRE)--BTG plc (LSE: BTG), the global healthcare company, highlighted the presentation of the two-year results for the SENTRY trial, at the Vascular Interventional Advances ...
Please provide your email address to receive an email when new articles are posted on . Early results suggest that retrievable inferior vena cava filters can be removed with a more than 85% rate of ...
The treatment of choice for proximal venous thrombosis is anticoagulation. In situations where anticoagulation is absolutely contraindicated or when anticoagulation has failed in the face of an acute ...
Recently published data suggesting that Bard’s Recovery and G2 vena cava filters are associated with an increased incidence of fracture and embolization has resulted in the FDA’s initiation of ...
Unsealed court documents from lawsuits over inferior vena cava (IVC) filters expose a big gap between what manufacturers and regulators know about the safety of a medical device and how much of that ...
Dear Dr. Roach: In November 1997, while traveling, I had a pulmonary embolism. I was treated with urokinase to the lungs and a vena cava filter was placed. In November 2006, I had a CT scan of my ...
Despite clinical trial data showing inferior vena cava (IVC) filters are ineffective for reducing mortality following deep vein thrombosis (DVT), as well as guideline recommendations against their use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback